157 related articles for article (PubMed ID: 7728979)
1. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone.
Han X; Liehr JG; Bosland MC
Carcinogenesis; 1995 Apr; 16(4):951-4. PubMed ID: 7728979
[TBL] [Abstract][Full Text] [Related]
2. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.
Bosland MC; Ford H; Horton L
Carcinogenesis; 1995 Jun; 16(6):1311-7. PubMed ID: 7788848
[TBL] [Abstract][Full Text] [Related]
3. Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.
Ozten N; Vega K; Liehr J; Huang X; Horton L; Cavalieri EL; Rogan EG; Bosland MC
Horm Cancer; 2019 Jun; 10(2-3):77-88. PubMed ID: 30877616
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
Ofner P; Bosland MC; Vena RL
Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
[TBL] [Abstract][Full Text] [Related]
5. Multistage prostate carcinogenesis: the role of hormones.
Bosland MC; Dreef-Van Der Meulen HC; Sukumar S; Ofner P; Leav I; Han X; Liehr JG
Princess Takamatsu Symp; 1991; 22():109-23. PubMed ID: 1844235
[TBL] [Abstract][Full Text] [Related]
6. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum and tissue zinc levels in sex hormone-induced prostatic carcinogenesis in the noble rat.
Wong YC; Wang YZ; Lee JS; Tam NN; Lee D
Tumour Biol; 2000; 21(6):328-36. PubMed ID: 11006573
[TBL] [Abstract][Full Text] [Related]
8. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.
Shirai T; Tamano S; Kato T; Iwasaki S; Takahashi S; Ito N
Cancer Res; 1991 Feb; 51(4):1264-9. PubMed ID: 1997167
[TBL] [Abstract][Full Text] [Related]
9. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
[TBL] [Abstract][Full Text] [Related]
10. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
[TBL] [Abstract][Full Text] [Related]
11. DNA adducts in target and nontarget tissues of 3,2'-dimethyl-4-aminobiphenyl in rats.
Shirai T; Tada M; Kojima M; Hasegawa R; Masui T; Ito N
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):167-72. PubMed ID: 7889841
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906
[TBL] [Abstract][Full Text] [Related]
13. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone.
Tamano S; Rehm S; Waalkes MP; Ward JM
Vet Pathol; 1996 Sep; 33(5):557-67. PubMed ID: 8885183
[TBL] [Abstract][Full Text] [Related]
14. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats.
Lane KE; Ricci MJ; Ho SM
Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603
[TBL] [Abstract][Full Text] [Related]
15. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
16. 32P-postlabeling analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level.
Shimomura M; Higashi S; Mizumoto R
Jpn J Cancer Res; 1992 May; 83(5):438-44. PubMed ID: 1319983
[TBL] [Abstract][Full Text] [Related]
17. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
[TBL] [Abstract][Full Text] [Related]
18. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
Hatcher JF; Swaminathan S
Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
[TBL] [Abstract][Full Text] [Related]
19. Comparative 32P-postlabeling analysis of benzo[a]pyrene--DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes.
Roggeband R; Wolterbeek AP; Rutten AA; Baan RA
Carcinogenesis; 1993 Sep; 14(9):1945-50. PubMed ID: 8403223
[TBL] [Abstract][Full Text] [Related]
20. Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.
Iwasaki S; Kato K; Mori T; Takahashi S; Futakuchi M; Shirai T
Jpn J Cancer Res; 1999 Jan; 90(1):23-30. PubMed ID: 10076561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
